ClinConnect ClinConnect Logo
Search / Trial NCT02732249

Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment

Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Apr 4, 2016

Trial Information

Current as of July 21, 2025

Completed

Keywords

Helicobacter Pylori Clarithromycin Amoxicillin Metronidazole Eradication

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants with non-ulcer functional dyspepsia or scarred peptic ulcer disease
  • Ability and willingness to participate in the study and to sign and give informed consent
  • confirmed H. pylori infection
  • Exclusion Criteria:
  • Previous H. pylori eradication therapy
  • Less than 18 years old
  • With history of H. pylori infection treatment
  • With previous gastric surgery
  • Major systemic diseases
  • Pregnancy or lactation
  • Allergy to any of the study drugs
  • Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion

About Shanghai Jiao Tong University School Of Medicine

Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Hong lu, MD

Principal Investigator

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials